Amino Acid Residues Involved in Inhibition of Host Gene Expression by Influenza A/Brevig Mission/1/1918 PA-X.

PA PA-X bacteria-based screening influenza A virus shutoff

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
20 May 2021
Historique:
received: 20 04 2021
revised: 19 05 2021
accepted: 19 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

The influenza A virus (IAV) PA-X protein is a virulence factor that selectively degrades host mRNAs leading to protein shutoff. This function modulates host inflammation, antiviral responses, cell apoptosis, and pathogenesis. In this work we describe a novel approach based on the use of bacteria and plasmid encoding of the PA-X gene under the control of the bacteriophage T7 promoter to identify amino acid residues important for A/Brevig Mission/1/1918 H1N1 PA-X's shutoff activity. Using this system, we have identified PA-X mutants encoding single or double amino acid changes, which diminish its host shutoff activity, as well as its ability to counteract interferon responses upon viral infection. This novel bacteria-based approach could be used for the identification of viral proteins that inhibit host gene expression as well as the amino acid residues responsible for inhibition of host gene expression.

Identifiants

pubmed: 34065592
pii: microorganisms9051109
doi: 10.3390/microorganisms9051109
pmc: PMC8160905
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI145332
Pays : United States
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : RTI-2018-094213-A-I00
Organisme : Spanish Ministry of Science, Innovation and Universities
ID : "Ramon y Cajal" Incorporation grant (RYC-2017)
Organisme : New York Influenza Center of Excellence (NYICE), a member of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services,
ID : Centers of Excellence for Influenza Research and Surveillance (CEIRS) contract No. HHSN272201400005C (NYICE)

Références

Med Microbiol Immunol. 2016 Aug;205(4):381-95
pubmed: 27289459
J Virol. 2007 Jul;81(13):7011-21
pubmed: 17442719
J Virol. 2020 May 18;94(11):
pubmed: 32161172
Emerg Infect Dis. 2006 Jan;12(1):15-22
pubmed: 16494711
J Virol. 2016 Jul 27;90(16):7131-7141
pubmed: 27226377
J Virol. 2012 Nov;86(22):12411-3
pubmed: 22951836
J Virol. 2017 Aug 10;91(17):
pubmed: 28637750
PLoS Pathog. 2016 Feb 05;12(2):e1005427
pubmed: 26849127
Nat Rev Immunol. 2014 May;14(5):315-28
pubmed: 24762827
Bull Hist Med. 2002 Spring;76(1):105-15
pubmed: 11875246
J Gen Virol. 2015 Sep;96(9):2587-2594
pubmed: 26296365
BMC Med. 2020 Dec 2;18(1):377
pubmed: 33261599
Vet Microbiol. 2020 Dec;251:108916
pubmed: 33197868
J Gen Virol. 2015 Aug;96(8):2036-2049
pubmed: 25877935
Proc Natl Acad Sci U S A. 2010 May 11;107(19):8778-81
pubmed: 20421481
J Virol. 2021 Apr 14;:JVI0040821
pubmed: 33853954
Nature. 2009 Apr 16;458(7240):914-8
pubmed: 19194459
Front Microbiol. 2014 Apr 17;5:172
pubmed: 24860555
Cell Rep. 2019 Apr 16;27(3):776-792.e7
pubmed: 30995476
Rev Sci Tech. 2009 Apr;28(1):187-202
pubmed: 19618626
J Virol. 2015 Apr;89(8):4126-42
pubmed: 25631083
Virology. 2018 Mar;516:71-75
pubmed: 29331676
J Virol. 2013 Mar;87(6):3108-18
pubmed: 23283952
Science. 2009 Jul 10;325(5937):197-201
pubmed: 19465683
Ann N Y Acad Sci. 2007 Apr;1102:1-25
pubmed: 17470908
PLoS Pathog. 2014 Jul 10;10(7):e1004217
pubmed: 25010204
J Virol. 2020 Jul 16;94(15):
pubmed: 32461313
J Virol. 2015 Aug;89(16):8661-5
pubmed: 26041295
Nature. 2009 Apr 16;458(7240):909-13
pubmed: 19194458
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
N Engl J Med. 2009 Jul 9;361(2):115-9
pubmed: 19474418
Science. 2012 Jul 13;337(6091):199-204
pubmed: 22745253
Viruses. 2018 Dec 12;10(12):
pubmed: 30545063
Cold Spring Harb Perspect Med. 2020 Jul 1;10(7):
pubmed: 31871237
J Virol. 2006 Aug;80(16):7789-98
pubmed: 16873236
Sci Rep. 2015 Feb 05;5:8262
pubmed: 25652161
J Virol. 2021 Jan 27;:
pubmed: 33504608
J Virol. 2018 Sep 12;92(19):
pubmed: 30021892
Virology. 2016 Nov;498:1-8
pubmed: 27525812
Virology. 2017 Apr;504:25-35
pubmed: 28142079

Auteurs

Kevin Chiem (K)

Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.

Luis Martinez-Sobrido (L)

Department of Disease Intervention and Prevention, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.

Aitor Nogales (A)

Center for Animal Health Research, INIA-CISA, Valdeolmos, 28130 Madrid, Spain.

Marta L DeDiego (ML)

Department of Molecular and Cell Biology, Centro Nacional de Biotecnología (CNB-CSIC), Campus Universidad Autónoma de Madrid, 28049 Madrid, Spain.

Classifications MeSH